CoChat

Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth

Langenbruch, A., Radtke, M., Franzke, N., Ring, J., Foelster‐Holst, R., Augustin, M. · 2014 · Journal of the European Academy of Dermatology and Venereology
Cited by 60

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: The successful treatment of atopic eczema (AE) should result in the improvement of both physical symptoms and patient′s quality of life (QoL). This study was conducted using a sample of dermatologists throughout Germany. This is due to dermatologists being the main health care providers of AE. Objectives: Obtaining reliable data on quality of care of AE from both the patient's and the physician's perspective. Methods: This cross‐sectional study assessed: the individual clinical history; dermatology‐specific QoL (DLQI); state of health (EQ‐5d‐VAS); treatments; burden caused by disease and treatment; patient‐defined treatment benefit (PBI). Results: Data from 1678 adult patients (60.5% female, mean age: 38.4 ± 15.9) were analysed. The most frequently used treatments during the last five years were emollients (90.4%) and topical corticosteroids (85.5%). In this study, 75.8% of the patients felt only moderately or not at all impaired by their treatment. The mean DLQI (0 = minimum–30 = maximum QoL impairment) was 8.5 ± 6.5. The EQ‐5d‐VAS (100 = best possible) was 63.6 ± 22.0 on average. 26.6% reported suffering ‘often’ or ‘every night’ from sleeplessness due to severe itching. Mean PBI was 2.4 ± 1.1 (4 = maximum benefit). Conclusions: This study provides first data on the health care of adults with AE in Germany at a national level and reveals the need for a more effective care. Whereas most patients consider their treatment‐related burden as low, the daily burden of the disease seems to be high: one third reports sleeplessness due to itching which indicates insufficient therapeutic regimes in these cases. A better implementation of the German national guideline for AE and a systematic analysis of the difficulties causing its limited effects is needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jdv.12154

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 60

Metadata

Authors
Langenbruch, A., Radtke, M., Franzke, N., Ring, J., Foelster‐Holst, R., & Augustin, M.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2013-04-05
Volume
28
Issue
6
Pages
719-726
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2044423858
Cited by
60
References
4
FWCI
4.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth. https://app.cochat.ai/papers/10.1111/jdv.12154
The paper
Langenbruch, A., Radtke, M., Franzke, N., Ring, J., Foelster‐Holst, R., & Augustin, M. (2014). Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.12154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.